Instrument Inactif

Communiqués IntelliPharmaCeutics International Inc. OTC Bulletin Board

Actions

CA4581733090

Communiqués

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Canadian Investment Regulatory Organization Trading Halt - IPCI	06/03	AQ
Intellipharmaceutics: Fiscal Q3 Earnings Snapshot	16/10/23	AQ
Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED AUGUST 31, 2023 - Form 6-K	16/10/23	PU
Intellipharmaceutics International : Reports Director Election Results - Form 6-K	06/10/23	PU
Intellipharmaceutics International : Appointment of Proxyholder - Form 6-K	06/10/23	PU
Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K	26/09/23	PU
Intellipharmaceutics Announces Second Quarter 2023 Results	17/07/23	AQ
Intellipharmaceutics: Fiscal Q2 Earnings Snapshot	14/07/23	AQ
Canadian Investment Regulatory Organization Trade Resumption - IPCI	08/06/23	AQ
Intellipharmaceutics: Fiscal Q4 Earnings Snapshot	06/06/23	AQ
Intellipharmaceutics: Fiscal Q1 Earnings Snapshot	06/06/23	AQ
Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results	06/06/23	AQ
Intellipharmaceutics Announces Cease Trade Order	07/03/23	AQ
IIROC Trading Halt - IPCI	07/03/23	AQ
Intellipharmaceutics Provides Update on Management Cease Trade Order Application and Anticipates Cease Trade Order	08/02/23	AQ
Intellipharmaceutics Announces its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form and its Management Cease Trade Order Application	06/02/23	AQ
Intellipharmaceutics: Fiscal Q3 Earnings Snapshot	14/10/22	AQ
Intellipharmaceutics International : Signs an Exclusive License & Supply Agreement with Taro Pharmaceuticals Inc. for Desvenlafaxine Extended-Release Tablets	16/08/22	PU
Intellipharmaceutics International : MANAGEMENT DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS - Form 6-K	21/07/22	PU
Intellipharmaceutics International : Announces Second Quarter 2022 Results	21/07/22	PU

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués IntelliPharmaCeutics International Inc. OTC Bulletin Board

Actions

CA4581733090

Communiqués

Filtres